ROIVANT SCIENCES LTD (ROIV) Stock Income Statement
NASDAQ:ROIV - BMG762791017 - Common Stock
11.93 USD
-0.01 (-0.08%)
11.93 USD
0 (0%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.23M | 29.05M | 32.71M | 61.28M | 55.29M | |||
| Minority Interest Expense | 197.50M | 184.75M | 117.72M | 106.43M | 78.85M | |||
| Cost Of Goods | 852.00K | 911.00K | 1.60M | 13.13M | 8.97M | |||
| Gross Profit | 22.38M | 28.14M | 31.11M | 48.15M | 46.32M | |||
| Operating Expenses | 1.21B | 1.14B | 856.04M | 1.22B | 1.40B | |||
| Research and Development | 582.83M | 550.41M | 439.91M | 622.96M | 622.93M | |||
| Selling, General, and Administrative Expenses | 625.54M | 591.41M | 416.13M | 600.51M | 775.03M | |||
| Operating Income | -1.19B | -1.11B | -824.93M | -1.18B | -1.35B | |||
| Interest Income/Expense | 255.41M | 313.56M | 98.45M | -16.60M | 349.79M | |||
| Other Income/Expense | -3.74M | 5.04M | -60.40M | -62.19M | 6.59M | |||
| Non Recurring Items | 3.11M | 113.50M | 5.35B | 29.28M | 71.51M | |||
| Income Before Taxes | -931.21M | -681.59M | 4.57B | -1.22B | -923.75M | |||
| Income Tax | 40.86M | 48.17M | 21.50M | 5.19M | 370.00K | |||
| Net Income | -490.63M | -171.98M | 4.35B | -1.01B | -845.26M | |||
| EBITDA | -1.18B | -1.10B | -802.89M | -1.16B | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.70 | -0.23 | 5.23 | -1.41 | -1.26 | |||
| Non GAAP EPS | -0.70 | -0.25 | -1.27 | -1.59 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.33% | 96.86% | 95.11% | 78.57% | 83.78% | |||
| Profit Margin | -2111.79% | -591.96% | 13294.18% | -1646.59% | -1528.78% | |||
| Operating Profit Margin | -5104.73% | -3833.27% | -2521.71% | -1917.95% | -2444.64% | |||
All data in USD